DAX23.239 +0,6%Est505.529 +0,3%MSCI World4.343 -0,1%Top 10 Crypto12,37 +5,6%Nas22.849 +2,6%Bitcoin76.677 +1,7%Euro1,1524 +0,1%Öl63,27 +1,2%Gold4.113 +1,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Bayer BAY001 NVIDIA 918422 Novo Nordisk A3EU6F RENK RENK73 DroneShield A2DMAA Siemens Energy ENER6Y Lufthansa 823212 Alphabet A (ex Google) A14Y6F Deutsche Telekom 555750 HENSOLDT HAG000 TKMS thyssenkrupp Marine Systems TKMS00 Amazon 906866 BASF BASF11 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX letztlich höher -- Novo Nordisk scheitert bei Alzheimer-Studie -- Deutsche Telekom, Alphabet, TKMS, D-Wave, DroneShield, Siemens Energy, Rheinmetall & Co., DHL, Bayer, Lufthansa, NEL im Fokus
Top News
Wie viel eine Ethereum Classic-Investition von vor 1 Jahr gekostet hätte Wie viel eine Ethereum Classic-Investition von vor 1 Jahr gekostet hätte
So lohnend wäre ein Einstieg in Bitcoin Cash von vor 1 Jahr gewesen So lohnend wäre ein Einstieg in Bitcoin Cash von vor 1 Jahr gewesen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Anixa Biosciences Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
3,88 EUR +0,10 EUR +2,65 %
FSE
4,38 USD +0,04 USD +0,92 %
BTT
Anixa Biosciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.124,04 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N6ZF

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS03528H1095

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolANIX

Anixa Biosciences Aktien News

DatumMeistgelesen
PR NewswireAnixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Comme...
PR NewswireAnixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
ZacksIs Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?
Wer­bungAnixa Biosciences-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireAnixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
PR NewswireAnixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
PR NewswireAnixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
ZacksAre You Looking for a Top Momentum Pick? Why ANIXA BIOSCIENCES INC (ANIX) is a Great Choice
PR NewswireAnixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
PR NewswireCleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
PR NewswireAnixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
PR NewswireAnixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
PR NewswireAnixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
PR NewswireAnixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
PR NewswireAnixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology
PR NewswireAnixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference
PR NewswireAnixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial
PR NewswireAnixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology
ZacksIs Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?
PR NewswireAnixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s
ZacksIs Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?
PR NewswireAnixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
ZacksANIXA BIOSCIENCES INC (ANIX) is a Great Momentum Stock: Should You Buy?
ZacksAre Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?
PR NewswireAnixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences to Host an Investor Webcast on June 26, 2025
ZacksWhat Makes ANIXA BIOSCIENCES INC (ANIX) a Strong Momentum Stock: Buy Now?
PR NewswireAnixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025
ZacksAll You Need to Know About Anixa Biosciences (ANIX) Rating Upgrade to Buy
ZacksAre Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?
PR NewswireAnixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine
PR NewswireAnixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
PR NewswireAnixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
PR NewswireAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
PR NewswireAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
BenzingaEXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent
PR NewswireAnixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
PR NewswireAnixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
BenzingaEXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines
PR NewswireAnixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

Anixa Biosciences News

Anixa Biosciences News: auf dieser Seite finden Sie alle Anixa Biosciences News und Nachrichten zur Anixa Biosciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Anixa Biosciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Anixa Biosciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.